Indian company launches drug to treat mild, moderate Covid-19 patients; another gunfight breaks out in Kashmir

  • 📰 staronline
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 75%

Business News News

Business Business Latest News,Business Business Headlines

MUMBAI (Xinhua): Glenmark Pharmaceuticals has become the first Indian company to launch anti-viral drug Favipiravir for the treatment of mild to moderate Covid-19 patients in the domestic market following the manufacturing approval from the drug regulator, a company statement said.

Launched under the brand name FabiFlu, the oral drug will be available as a prescription-based medication for US$1.35 per tablet.

It offers rapid reduction in viral load within four days and has shown clinical improvement of up to 88 per cent in mild to moderate Covid-19 cases, it added. In another development, a gunfight between militants and government forces broke out Sunday in restive Indian-controlled Kashmir, police said."A gunfight started between militants and joint contingents of police and paramilitary at Zadibal-Soura area of the city early today," a police spokesman said."The stand-off is underway."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in BUSİNESS

Business Business Latest News, Business Business Headlines